# Nucleic Acid Amplification Testing (NAT) of Blood Donors for HCV and HIV

> **NCT00004846** · — · COMPLETED · sponsor: **National Institutes of Health Clinical Center (CC)** · enrollment: 30000 (—)

## Conditions studied

- Hepatitis C
- HIV Infection

## Interventions

- **DRUG:** ABC/Gen-Probe/Chiron HIV-1/HCV 001

## Key facts

- **NCT ID:** NCT00004846
- **Lead sponsor:** National Institutes of Health Clinical Center (CC)
- **Sponsor class:** NIH
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 1999-12
- **Primary completion:** —
- **Final completion:** 2002-10
- **Target enrollment:** 30000 (—)
- **Last updated:** 2008-03-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00004846

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00004846, "Nucleic Acid Amplification Testing (NAT) of Blood Donors for HCV and HIV". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT00004846. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*